Objective-During hypoxia, active substances released by the endothelium play a key role in the cardiovascular and respiratory responses elicited to optimize oxygen delivery. As hypercholesterolemia is a major cause of endothelial dysfunction, it may interfere with these responses.
A cute systemic hypoxia is a very common clinical manifestation of several cardiovascular syndromes such as heart failure, shock, and pulmonary edema. Intermittent acute episodes of systemic hypoxia are also the most important pathophysiological event in sleep apnea syndrome, which is frequently associated with cardiovascular disease. During hypoxia, integrated cardiovascular and respiratory responses critical for maintaining life are activated to compensate for the decrease in oxygen delivery. 1, 2 Cardiovascular adjustments to systemic hypoxia depend not only on neural mechanisms but also on endothelium, which synthesizes and releases vasoactive substances. [3] [4] [5] [6] It has been demonstrated that during acute hypoxia in humans, the increase in sympathetic nerve activity to muscle evaluated by microneurography 3 is associated with a decrease in muscular vascular resistance. 6 It has been proposed that the endothelial release of nitric oxide (NO) and adenosine plays a role in this vasorelaxation. 6, 7 Moreover, endothelium-derived NO and adenosine produced within the carotid body may modulate ventilatory responses to acute hypoxia. 8 Hypercholesterolemia (HC) is a major risk factor for ischemic cardiomyopathy and is frequently associated with hypertensive heart disease. There is also evidence that patients with sleep apnea syndrome often have hypercholesterolemia. 9 Consequently, HC is associated with several syndromes that may involve episodes of acute hypoxia. HC is also an important cause of endothelial dysfunction, the hallmark of which is altered vasorelaxation in response to endothelial-dependent vasodilators. 10 Moreover, a study in vitro demonstrated that HC impairs the relaxation of the carotid artery to hypoxia. 11 Thus, it is reasonable to hypothesize that endothelial dysfunction associated with HC may impair compensatory vascular and also the ventilatory responses during systemic hypoxia in humans. To our best knowledge, the actual consequences of this combination of conditions in humans are unknown. Therefore, we investigated and compared cardiovascular and respiratory responses to acute systemic hypoxia between patients with isolated HC and healthy control subjects.
Methods Subjects
A carefully selected population of 14 consecutive patients with isolated HC (mean age: 39Ϯ3 years, range: 18 to 55 years; 7 women and 7 men; total cholesterol: 310Ϯ14 mg/dL, range: 250 to 445 mg/dL; LDL cholesterol: 234Ϯ14 mg/dL, range: 174 to 366 mg/dL; triglycerides: 119Ϯ12 mg/dL, range: 78 to 188 mg/dL) were studied. These patients had been referred to the Lipid Clinics of the Heart Institute of the University of São Paulo for evaluation of HC. Eleven presented with a diagnosis of familial hypercholesterolemia. 12 Extreme caution was exercised to avoid the presence of confounding factors (eg, hypertension, sleep apnea syndrome, diabetes, smoking) in this patient group. No patient had received lipid-lowering drugs during the 2 months preceding the study. In addition, patients older than 40 years underwent a treadmill stress test to rule out silent myocardial ischemia.
The control (CO) group consisted of 13 normal volunteers (age: 37Ϯ2.2 years, range: 22 to 46 years; 7 women and 6 men) who were matched to patients in the HC group in regard to age, sex, body mass index, and office blood pressure measurements (Table 1) . Individuals in the CO group had a normal total cholesterol concentration (173Ϯ4 mg/dL, range: 149 to 192 mg/dL). Only 2 subjects had an LDL cholesterol level Ͼ130 mg/dL (mean LDL cholesterol: 124Ϯ5.6 mg/dL, range: 92 to 144 mg/dL), and all subjects had a triglyceride level Ͻ200 mg/dL (triglycerides: 94Ϯ13, range: 49 to 182 mg/dL).
All subjects provided informed, written consent to participate, and the study was approved by the Ethics Committee of the Heart Institute of the University of São Paulo. All procedures followed were in accordance with institutional guidelines.
Cardiovascular Monitoring
Arterial pressure was continuously monitored by the volume clamp method (Finapress Ohmeda 2300-Ohmeda Monitoring Systems). The heart rate was monitored by electrocardiography. As an indirect estimate of myocardial oxygen uptake, the rate pressure product was calculated as the product of the systolic arterial pressure and heart rate. Forearm blood flow was measured in the right arm by venous occlusion plethysmography (D.E. Hokansen, Model EC-4). Forearm flow measurements were recorded for intervals of approximately 10 seconds every 20 seconds. Three readings were obtained for each mean minute value. Forearm vascular resistance was calculated as the mean arterial pressure during a one-minute record divided by the mean minute forearm blood flow.
Respiratory Monitoring
The end-tidal carbon dioxide (CO 2 ) and oxygen saturation were monitored with a capnograph and pulse oximeter (Novametrix model 7100 CO 2 SMO ETCO 2 / SpO 2 Monitor, Novametrix Medical Systems Inc), respectively. Minute ventilation was monitored with a pneumotachograph (Heated Pneumotachometer, Hans-Rudolph, Inc) and a differential pressure transducer (MP 45 to 871 Validyne, Engineering Corporation) linked to a signal integrator amplifier (Gould Instruments Systems, Inc).
All signals were recorded simultaneously on a Gould strip-chart recorder (RS 3800, Gould Instruments Systems, Inc) and on a computer using customized CODAS software (Computer Operated Data Acquisition Software; AT-CODAS; DATAQ Instruments).
Experimental Protocol and Procedures
An established protocol currently used by Somers et al 3 and by our group was used. 13 The individuals were not allowed to drink caffeinated products on the morning of the test. Studies were initiated after at least a 20-minute rest period in the supine position in a quiet room. Measurements were obtained for 2 minutes while the subjects breathed room air (baseline recording) and then for 5 minutes (analyzed using a minute-by-minute format) during isocapnic hypoxia. The latter was induced by administering 10% O 2 in N 2 with titrated CO 2 via a mouthpiece, using a noseclip to ensure exclusive mouthbreathing.
Statistical Analyses
Statistical analyses were performed with SAS software. Demographic data and baseline measurements were compared using 2-tailed unpaired t test. The gender distribution was compared using Fisher's exact test.
Responses to hypoxia were assessed by comparing baseline values with the mean values obtained during minutes 3, 4, and 5 of isocapnic hypoxia (ie, steady-state of the response to hypoxia); analysis of variance for repeated-measures was used for this comparison, with time (baseline versus intervention) as the within factor and group (CO versus CH) as the between factor. The key effect was the group-by-time interaction. Graphics show the changes in variables that occurred during minutes 3, 4, and 5 of hypoxia compared with baselines values. Data are presented as the meanϮSEM. A probability value of Ͻ0.05 was considered significant.
Results

Subject Characteristics
The mean age, body mass index, sex distribution, arterial blood pressure, HDL cholesterol level, triglyceride level, fasting glucose level, and hemoglobin were similar between groups ( Table 1) .
Resting Values
At baseline, the mean oxygen saturation, end-tidal CO 2 , minute ventilation, heart rate, and systolic, diastolic and mean arterial pressure in patients with HC were similar to values in CO subjects. Although a trend toward higher forearm blood flow and lower forearm vascular resistance was observed in the HC group, these differences were not statistically significant (Pϭ0.09 and Pϭ0.07, respectively). The baseline rate pressure product was higher in the HC group compared with the CO group (Pϭ0.03) ( Table 2 ).
Responses to Isocapnic Hypoxia
The magnitude of the hypoxia-induced decrease in oxygen saturation was similar in both groups ( Table 3 and Figure 1 ), and the isocapnia was maintained ( Table 3 ). Both groups had similar increases in minute ventilation during the hypoxia ( Table 3 and Figure 1 ). Blood pressure values represent the mean of two consecutive measurements obtained with a mercury manometer after the patients had been sitting for Ϸ10 minutes in a calm room. Values are presented as meanϮSE.
The marked increase in heart rate observed in the hypercholesterolemic patients was comparable to that in the CO subjects (Table 3 and Figure 2 ).
Diastolic blood pressure did not increase in the CO subjects (Pϭ0.08) but increased in the hypercholesterolemic patients (Pϭ0.0002). The mean arterial blood pressure increased in both groups but to a greater extent in the HC group (Pϭ0.05). Moreover, despite the significant increase in systolic blood pressure in the HC group, 140Ϯ4 mm Hg (95% confidence interval [CI],131 to 149 mm Hg) to 154Ϯ4 mm Hg (95% CI, 145 to 164 mm Hg) (Pϭ0.0001), and in the CO group, 133Ϯ3 (95% CI,126 to 140 mm Hg) to 140Ϯ4 mm Hg (95% CI, 132 to 148 mm Hg) (Pϭ0.0017), hypercholesterolemic patients showed an enhanced pressor response (Pϭ0.03, group comparison). In addition, the increase in the rate pressure product was significantly higher in patients with HC compared with CO subjects (Pϭ0.02, group comparison) (Table 3 and Figures 2, 3, and 4 ). Whereas 7 both groups demonstrated a similar increase in forearm blood flow, the decrease in forearm vascular resistance observed in the CO group (Pϭ0.0001), 40Ϯ5 (95% CI,30 to 51 UR) to 31Ϯ4 UR (95% CI,23 to 39 UR), was not seen in the HC group (Pϭ0.14), 29Ϯ3 (95% CI, 22 to 37 UR) to 26Ϯ3 UR (95% CI, 20 to 33 UR; Pϭ0.03, group comparison) (Table 3 and Figures 2, 3, and 4 ).
Discussion
This is the first study to investigate integrated respiratory and cardiovascular responses to acute systemic hypoxia in humans with HC. The major findings are that, while the ventilatory response is not impaired, cardiovascular responses are altered. First, hypercholesterolemic patients demonstrate hyperreactivity of the pressor response. Second, patients with The effects of systemic hypoxia on the cardiovascular system are complex and interdependent. They include the reflex effects of peripheral chemoreceptor stimulation, secondary effects of chemoreceptor-induced hyperventilation, effects arising from the influence of hypoxia on the central nervous system, effects of circulating hormones, and local effects on the heart and blood vessels. 2 The first major finding in this study was the hyperreactive pressor response to the systemic hypoxia in the HC group. The overall systemic hemodynamic response during hypoxia reflects the increase in cardiac output and decrease in systemic vascular resistance. 2, 5 We found that only the hypercholesterolemic patients demonstrated an increase in diastolic blood pressure. Moreover, patients with severe HC exhibited greater systolic and mean blood pressure responses to isocapnic hypoxia. These findings reinforce the hypothesis that HC may interfere with blood pressure homeostasis 14 -16 and raise several important possibilities. First, the decrease in the systemic vascular resistance during hypoxia depends on the bioavailability of NO, which is decreased in patients with HC. 5 Second, HC may be associated with a reduction in aortic compliance, which may disrupt acute modulation of the increase in cardiac output that occurs during hypoxia. 17 Third, we observed a trend toward an enhanced heart rate response in the HC group; thus, an elevated cardiac output response cannot be ruled out.
The tendency toward a greater heart rate response in the patients with hypercholesterolemia, considering the greater increase in systolic blood pressure, was unexpected. The baroreflex modulates the cardiovascular responses during systemic hypoxia, 18 and HC may be associated with depressed baroreflex function due to functional and/or structural factors. 19 -21 Thus, the heart rate response may occur partially, as a consequence of baroreflex impairment.
In normal humans, despite the increase in muscle sympathetic activity during systemic hypoxia, 3 the net effect in territories of skeletal muscle vasculature is vasodilation. [5] [6] [7] 13 Evidence strongly suggests that the synthesis and release of vasoactive substances by the endothelium plays a key role. [5] [6] [7] The second major finding was that, despite similar levels of hypoxia, the decrease in forearm vascular resistance normally observed was absent in our patients with HC. Several hypotheses may explain this finding. First, there is enhanced sympathetic activity to muscle vasculature during systemic hypoxia. Unfortunately, we did not measure sympathetic nerve activity to muscle in our patients to evaluate the neural component of this vascular response. Nevertheless, Narkiewicz et al 22 and our group 13 have previously demonstrated that the magnitude of these sympathetic changes parallels that of the ventilatory responses, and we observed no differences in the ventilatory responses between the HC and CO groups. Thus, it is tempting to propose that a selective potentiation of sympathetic nervous activity to muscle vasculature is not the sole explanation for the absence of vasorelaxation in our hypercholesterolemic patients.
Second, HC is characterized by coexisting endothelial dysfunction, the hallmark of which is altered vasodilation to endothelial-dependent vasodilators. 10 Thus, endothelial dysfunction associated with severe HC may have led to the impaired forearm vascular response to hypoxia in the HC group. Taguchi et al 23 demonstrated in vitro that relaxation of the carotid artery in response to mild and severe hypoxia is (Figure 1 ) did not elicit a decrease in forearm vascular resistance (UR) and was associated with greater increases in the systolic blood pressure (mm Hg) during minutes 3, 4, and 5 of isocapnic hypoxia in patients with HC (ⅷ) compared with responses in normal control subjects (⅙). The trend toward greater increases in heart rate (bpm) responses in patients with isolated HC compared with normal control subjects was not statistically significant. However, the rate pressure product was significantly enhanced in the patients with HC. Data are presented as the meanϮSEM.
†PϽ0.05 for group-by-time interaction. impaired in Watanabe heritable hyperlipidemic rabbits and that the vascular response is mediated by activation of glibenclamide-sensitive potassium channels and by endothelial factors. 11, 23 In humans, NO released by the endothelium and adenosine acting at endothelial A 1 receptors have been the most commonly implicated vasoactive substances in the forearm vasodilatory response to systemic hypoxia. 6, 7 Therefore, the abnormal vascular response we observed in the HC group during systemic hypoxia could, at least in part, reflect endothelial dysfunction associated with HC. Unfortunately, data correlating vasodilation elicited by acetylcholine and by systemic hypoxia are not available to permit evaluation of this maneuver (ie, induction of isocapnic hypoxia) as a surrogate test of endothelial function. 24 In vivo and in vitro studies indicate that NO modulates contractile responses to adrenergic stimulation. [25] [26] [27] Moreover, there is evidence of ␤-adrenergic vasodilation in human forearm mediated through NO via ␤ 2 receptors, also attenuating the vasoconstriction to cathecolamines. 28 Therefore, a more integrated hypothesis to explain our vascular finding is that, despite similar increases in sympathetic nervous system activity, the decreased bioavailability of NO associated with HC potentiated the neurogenic vascular response. Our hypercholesterolemic patients demonstrated an intriguing finding: a tendency toward a greater heart rate, systolic blood pressure, and forearm blood flow associated with reduced forearm vascular resistance during baseline measurements but absence of forearm vasorelaxation during systemic isocapnic hypoxia. Similar findings of coronary microvascular dysregulation have been demonstrated in patients with type 2 diabetes mellitus and characterized by elevated baseline blood flow, reduced baseline microvascular resistance, and an abnormal increase in resistance during the cold pressor test. 29 It was proposed that the degree of vasodilation at baseline limited the flow response to acute stress. 29 In addition, despite the 20-minute rest period that preceded the cardiorespiratory measurements, elements of our experimental preparation (eg, mouthpiece, noseclip) may have already been eliciting a mild alert or stress response. Thus, the tendency toward differences in baseline values between the groups (ie, trend toward higher forearm blood flow and lower forearm vascular resistance in the HC group) may already reflect a dysregulation of cardiovascular adjustments during minimally stressful situations. 14 In further support of this notion, we should emphasize that the baseline values in the present control group were similar to values observed in controls in our previous studies. 13, 30 
Clinical Implications
Acute episodes of systemic hypoxia may occur during critical phases of ischemic cardiomyopathy, and HC is a prevalent risk factor for this disease. HC is also a common metabolic finding in patients with sleep apnea syndrome. 9 Therefore, one would expect to encounter hypercholesterolemic patients experiencing episodes of systemic hypoxia in clinical practice.
The fact that the patients with HC demonstrated marked dysregulation of the cardiovascular responses to systemic hypoxia, characterized by the absence of forearm vasodilation associated with a hyperreactive pressor response, has several important clinical implications. The main one is that the skeletal muscle vascular response is an important adaptive response for optimizing oxygen delivery to vital territories during hypoxia. 2 Therefore, the marked blunting of muscle vasodilation in the hypercholesterolemic patients, which may compromise delivery of oxygen, deserves further attention.
The finding of an enhanced rate pressure product in the hypercholesterolemic patients indirectly suggests that HC is associated with a greater consumption of myocardial oxygen. In addition, it has been shown in an acetylcholine-induced vasodilation experiment that the coronary response correlates with flow-mediated brachial artery vasodilation in hypercholesterolemic patients. 31 Therefore, if hypercholesterolemic patients also manifest the same dysregulation of the coronary response during acute oxygen desaturation, the reduced oxygen delivery to cardiac muscle combined with a greater increase in myocardial oxygen demand may be critical. The impaired vasoregulation associated with hypercholesterolemia may underlie poor oxygen delivery to organs and tissues and elicit an enhanced pressor response to increase blood flow, augmenting myocardial oxygen demand. Taken together, it is possible that blunted vasorelaxation associated with enhanced cardiovascular reactivity may impose additional risk of cardiovascular events in hypercholesterolemic patients during acute systemic hypoxia.
